Journal article · 2025 · Open access
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation
Nature, 650(8102), 701–709 · Published 1 December 2025 · DOI 10.1038/s41586-025-09893-0
In brief
“Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation” is a 2025 journal article by Christian Gaebler and 38 co-authors, published in Nature. OpenAlex counts 29 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Nature.
- Citations
- 29
- Most cited in
- 2026 (28)
- Field-weighted impact
- 8.06
- References
- 81
- Authors
- 39
Abstract
HIV cure is exceptionally rare, with only six cases documented among the estimated 88 million individuals who have acquired HIV since the onset of the epidemic 1–6 . Successful cures, including that of the pioneering individual known as the Berlin patient, are limited to those who received allogeneic stem cell transplants (allo-SCTs) for haematological cancers. HIV resistance from stem cell donors with the rare homozygous CCR5Δ32 mutation was long considered the main mechanism for HIV remission without antiretroviral therapy. However, recent reports have highlighted CCR5-independent mechanisms as important contributors to HIV cure 6–8 . Here we provide new evidence for this conceptual shift, whereby long, treatment-free HIV remission was achieved after allo-SCT with functionally active CCR5. A man with heterozygous CCR5 wild-type/Δ32 living with HIV received allo-SCT from a HLA-matched unrelated heterozygous CCR5 wild-type/Δ32 donor as treatment for acute myeloid leukaemia. Three years after allo-SCT, the patient discontinued antiretroviral therapy. So far, HIV remission has been sustained for more than 6 years with undetectable plasma HIV RNA. Reservoir analysis revealed intact proviral HIV before transplantation, but no replication-competent virus in blood or intestinal tissues after allo-SCT. Declining or absent HIV-specific antibody and T cell responses support the absence of viral activity. High antibody-dependent cellular cytotoxicity activity at the time of transplantation may have contributed to HIV reservoir clearance. These results demonstrate that CCR5Δ32-mediated HIV resistance is not essential for durable remission, which underscores the importance of effective viral reservoir reductions in HIV cure strategies.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Gaebler, C., Kor, S., Allers, K., Perotti, M., Mwangi, D., Meixenberger, K., Hanke, K., Trenkner, T., Kraus, T., Sha, Y., Arentowicz, C., Odidika, S., Grahn, N., Scheck, R., Perkins, N., Pardons, M., Igbokwe, V., Corman, V. M., Burmeister, T., . . . Penack, O. (2025). Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation. Nature, 650(8102), 701–709. https://doi.org/10.1038/s41586-025-09893-0
MLA 9
Gaebler, Christian, et al. “Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation.” Nature, vol. 650, no. 8102, 2025, pp. 701–709. https://doi.org/10.1038/s41586-025-09893-0.
Chicago
Gaebler, Christian, Samad Kor, Kristina Allers, Michela Perotti, David Mwangi, Karolin Meixenberger, Kirsten Hanke, et al. 2025. “Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation.” Nature 650 (8102): 701–709. https://doi.org/10.1038/s41586-025-09893-0.
Harvard
Gaebler, C. et al. (2025) ‘Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation’, Nature, 650(8102), pp. 701–709. doi:10.1038/s41586-025-09893-0.
IEEE
C. Gaebler et al., “Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation,” Nature, vol. 650, no. 8102, pp. 701–709, 2025, doi: 10.1038/s41586-025-09893-0.
BibTeX
@article{gaebler2025sustained,
title = {{Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation}},
author = {Gaebler, Christian and Kor, Samad and Allers, Kristina and Perotti, Michela and Mwangi, David and Meixenberger, Karolin and Hanke, Kirsten and Trenkner, Timo and Kraus, Tom and Sha, Yeqin and Arentowicz, Carmen and Odidika, Stanley and Grahn, Nikolai and Scheck, Rachel and Perkins, Naomi and Pardons, Marion and Igbokwe, Vanessa and Corman, Victor M. and Burmeister, Thomas and Blau, Olga and Sürücü, Gülüstan and Prüß, Axel and Schneider, Christian G. and Klausen, Gerd and Sauter, Jürgen and Klein, Florian and Sander, Leif Erik and Hofmann, Jörg and Vuong, Lam Giang and Bullinger, Lars and others},
journal = {Nature},
year = {2025},
volume = {650},
number = {8102},
pages = {701--709},
doi = {10.1038/s41586-025-09893-0},
url = {https://doi.org/10.1038/s41586-025-09893-0}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- HIV cure
- HIV remission
- CCR5Δ32
- allogeneic stem cell transplantation
- HIV reservoir
- acute myeloid leukemia
- antiretroviral therapy discontinuation
- antibody-dependent cellular cytotoxicity
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Gaebler, C., Kor, S., Allers, K., Perotti, M., Mwangi, D., Meixenberger, K., Hanke, K., Trenkner, T., Kraus, T., Sha, Y., Arentowicz, C., Odidika, S., Grahn, N., Scheck, R., Perkins, N., Pardons, M., Igbokwe, V., Corman, V. M., Burmeister, T., . . . Penack, O. (2025). Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation. Nature, 650(8102), 701–709. https://doi.org/10.1038/s41586-025-09893-0
How many times has this paper been cited?
29 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Nature: sign in and open the full text from this page.
Who wrote this paper?
Christian Gaebler, Samad Kor, Kristina Allers, Michela Perotti, David Mwangi, Karolin Meixenberger, Kirsten Hanke, Timo Trenkner, Tom Kraus, Yeqin Sha, Carmen Arentowicz, Stanley Odidika and 27 more.
What is the DOI of this paper?
10.1038/s41586-025-09893-0, permanently at https://doi.org/10.1038/s41586-025-09893-0. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.